Literature DB >> 25394289

Pound the alarm: danger signals in rheumatic diseases.

Steven O'Reilly1.   

Abstract

Damage-associated molecular patterns (DAMPs) are chemically heterogeneous endogenous host molecules rapidly released from damaged or dying cells that incite a sterile inflammatory response mediated via pattern recognition receptors (PRRs). The sources of DAMPs are dead or dying cells or the extracellular matrix and can signal through the PRRs, the Toll-like receptors or cytosolic Nod-like receptors, culminating in nuclear factor κB (NF-κB) activation and pro-inflammatory cytokine secretion. Together, these molecules are involved in sterile inflammation and many are associated with rheumatic autoimmune diseases such as rheumatoid arthritis, systemic lupus erythromatosus, psoriatic arthritis and systemic sclerosis. These diseases are associated with inflammation and many danger signals are found in sites of sterile inflammation and mediate inflammation. The present review examines the role of DAMPs in rheumatic conditions and suggests avenues for their therapeutic modulation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25394289     DOI: 10.1042/CS20140467

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  9 in total

Review 1.  Cell death in chronic inflammation: breaking the cycle to treat rheumatic disease.

Authors:  Holly Anderton; Ian P Wicks; John Silke
Journal:  Nat Rev Rheumatol       Date:  2020-07-08       Impact factor: 20.543

Review 2.  The danger from within: alarmins in arthritis.

Authors:  Meriam Nefla; Dirk Holzinger; Francis Berenbaum; Claire Jacques
Journal:  Nat Rev Rheumatol       Date:  2016-10-13       Impact factor: 20.543

Review 3.  Macrophages in Systemic Sclerosis: Novel Insights and Therapeutic Implications.

Authors:  Diana M Toledo; Patricia A Pioli
Journal:  Curr Rheumatol Rep       Date:  2019-05-23       Impact factor: 4.592

Review 4.  Application and prospect of targeting innate immune sensors in the treatment of autoimmune diseases.

Authors:  Jun Liu; Hui Zhang; Yanhong Su; Baojun Zhang
Journal:  Cell Biosci       Date:  2022-05-26       Impact factor: 9.584

5.  Mycobacterium tuberculosis Rv0309 Dampens the Inflammatory Response and Enhances Mycobacterial Survival.

Authors:  Yongchong Peng; Xiaojie Zhu; Lin Gao; Jieru Wang; Han Liu; Tingting Zhu; Yifan Zhu; Xin Tang; Changmin Hu; Xi Chen; Huanchun Chen; Yingyu Chen; Aizhen Guo
Journal:  Front Immunol       Date:  2022-02-24       Impact factor: 7.561

6.  Tenascin-C drives persistence of organ fibrosis.

Authors:  Swati Bhattacharyya; Wenxia Wang; Luisa Morales-Nebreda; Gang Feng; Minghua Wu; Xiaodong Zhou; Robert Lafyatis; Jungwha Lee; Monique Hinchcliff; Carol Feghali-Bostwick; Katja Lakota; G R Scott Budinger; Kirtee Raparia; Zenshiro Tamaki; John Varga
Journal:  Nat Commun       Date:  2016-06-03       Impact factor: 14.919

Review 7.  Novel insights into dendritic cells in the pathogenesis of systemic sclerosis.

Authors:  T Carvalheiro; M Zimmermann; T R D J Radstake; W Marut
Journal:  Clin Exp Immunol       Date:  2020-02-13       Impact factor: 4.330

8.  Fibronectin (FN) cooperated with TLR2/TLR4 receptor to promote innate immune responses of macrophages via binding to integrin β1.

Authors:  Dongsheng Fei; Xianglin Meng; Wei Yu; Songlin Yang; Ning Song; Yanhui Cao; Songgen Jin; Lina Dong; Shangha Pan; Mingyan Zhao
Journal:  Virulence       Date:  2018       Impact factor: 5.882

Review 9.  Upcoming treatments for morphea.

Authors:  Dan Wenzel; Nazgol-Sadat Haddadi; Khashayar Afshari; Jillian M Richmond; Mehdi Rashighi
Journal:  Immun Inflamm Dis       Date:  2021-07-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.